Page last updated: 2024-08-21

thiazolidines and Androgen-Independent Prostatic Cancer

thiazolidines has been researched along with Androgen-Independent Prostatic Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdulkadir, SA; Ahdesmaki, M; Anderson, PD; Everett, JH; Franco-Coronel, OE; Grosskurth, SE; Hameed, O; Huszar, D; Keeton, EK; Kirschner, AN; Kushner, MH; van der Meer, R; Wang, J	1

Other Studies

1 other study(ies) available for thiazolidines and Androgen-Independent Prostatic Cancer

Article	Year
PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer. Journal of the National Cancer Institute, 2015, Volume: 107, Issue:2 Topics: Administration, Oral; Allografts; Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Cell Hypoxia; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Male; Mice; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Thiazolidines; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2015

Article

Year

PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer.

Journal of the National Cancer Institute, 2015, Volume: 107, Issue:2

Topics: Administration, Oral; Allografts; Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Cell Hypoxia; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Male; Mice; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Thiazolidines; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2015